Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 12
- Next page
Title | Authors | Year | Journal Sort descending | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
ResearchUnit: Research into TRALI therapies gene therapy results that are a TAD interesting! | Semple J | 2014 | Blood.ca website | View ResearchUnit: Research into TRALI therapies gene therapy results that are a TAD interesting! | Other | Other |
Utilisation des produits sanguins CMV négatifs | Ryan J | 2017 | Blood.ca website | View Utilisation des produits sanguins CMV négatifs | Health care providers | Benchmarking and standard setting |
ResearchUnit: Improving the usefulness of a laboratory tool to match donors and patients | Acker J, Branch D | 2018 | Blood.ca website | View ResearchUnit: Improving the usefulness of a laboratory tool to match donors and patients | Other | Other |
Rapport de surveillance 2017 | O'Brien S | 2018 | Blood.ca website | View Rapport de surveillance 2017 | Other | Other |
ResearchUnit: Donating blood before pregnancy is safe for mothers and babies | Chassé M | 2020 | Blood.ca website | View ResearchUnit: Donating blood before pregnancy is safe for mothers and babies | Researchers | Clinical research |
Circular of information for the use of human blood components: Pathogen Reduced Platelet Concentrates | Stewart T | 2022 | Blood.ca website | View Circular of information for the use of human blood components: Pathogen Reduced Platelet Concentrates | Health care providers | Benchmarking and standard setting |
ResearchUnit: Whole blood: longer holding times before leukoreduction may be a safe to explore option | Chen ZY | 2022 | Blood.ca website | View ResearchUnit: Whole blood: longer holding times before leukoreduction may be a safe to explore option | Regulators | New or improved product or process |
ResearchUnit: Developing more inclusive deferral policies for blood and plasma donors | Goldman M, O'Brien S, Devine D | 2018 | Blood.ca website | View ResearchUnit: Developing more inclusive deferral policies for blood and plasma donors | Other | Other |
ResearchUnit: Where is the blood going? Understanding red blood cell utilization to inform policies | Zeller M, Heddle N, Devine D | 2017 | Blood.ca website | View ResearchUnit: Where is the blood going? Understanding red blood cell utilization to inform policies | Other | Other |
Concentré de recherche : Un sur un million : un modèle pour gérer les réserves de sang rare | Blake J, Clarke G | 2019 | Blood.ca website | View Concentré de recherche : Un sur un million : un modèle pour gérer les réserves de sang rare | Researchers | Clinical research |
Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Jenkins C | 2019 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Health care providers | Benchmarking and standard setting |
Système Kell : l’anticorps anti-Kpa | Peng S, Meunier D | 2019 | Blood.ca website | View Système Kell : l’anticorps anti-Kpa | Health care providers | Benchmarking and standard setting |
Circulaire d'information utilisation de composants sanguins humains: Plaquettes | Jenkins C | 2021 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
ResearchUnit: Natural killers: when cells go wrong | Ni H | 2017 | Blood.ca website | View ResearchUnit: Natural killers: when cells go wrong | Other | Other |
Syndrome respiratoire aigu post-transfusionnel (TRALI) | Petraszko T | 2019 | Blood.ca website | View Syndrome respiratoire aigu post-transfusionnel (TRALI) | Researchers | Clinical research |
Concentré de recherche: Concentré de fibrinogène vs cryoprécipité pour réduire les saignements après une chirurgie cardiaque | Karkouti K | 2020 | Blood.ca website | View Concentré de recherche: Concentré de fibrinogène vs cryoprécipité pour réduire les saignements après une chirurgie cardiaque | Health care providers | Clinical research |
MNS System: Anti-M | Clarke G, Côté J, Lane D | 2019 | Blood.ca website | View MNS System: Anti-M | Health care providers | Benchmarking and standard setting |
ResearchUnit: Fighting inflammation with inflammation | Lazarus A | 2019 | Blood.ca website | View ResearchUnit: Fighting inflammation with inflammation | Researchers | Clinical research |
Importance du fer chez les donneurs de sang total : la perspective canadienne | Khandelwal A, Pambrun C, Goldman M | 2023 | Blood.ca website | View Importance du fer chez les donneurs de sang total : la perspective canadienne | Health care providers | Benchmarking and standard setting |
FAQ: Whole blood, leukocytes reduced (LrWB) at Canadian Blood Services | Mack J | 2022 | Blood.ca website | View FAQ: Whole blood, leukocytes reduced (LrWB) at Canadian Blood Services | Health care providers | New or improved product or process |
Circulaire d'information utilisation de composants sanguins humains: Cellules progénitrices hématopiétiques de sang de cordon omilical | Stewart T | 2022 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Cellules progénitrices hématopiétiques de sang de cordon omilical | Health care providers | Benchmarking and standard setting |
Blood: the basics | Chargé S, Hodgkinson KM | 2017 | Blood.ca website | View Blood: the basics | Health care providers | Other |
Concentré de recherche: Cellules tueuses naturelles : quand les cellule perdent le nord! | Ni H | 2017 | Blood.ca website | View Concentré de recherche: Cellules tueuses naturelles : quand les cellule perdent le nord! | Researchers | Basic research |
Paying it forward: Why we need YOU to give blood | Callum J | 2017 | Blood.ca website | View Paying it forward: Why we need YOU to give blood | Health care providers | Other |
ResearchUnit: Searching for safer red blood cell bags for pediatric recipients | Serrano K, Acker J | 2016 | Blood.ca website | View ResearchUnit: Searching for safer red blood cell bags for pediatric recipients | Other | Other |
Concentré de recherche: Où l'on optimise un test de laboratoire pour déterminer la compatibilité entre donneurs et receveurs | Acker J, Branch D | 2018 | Blood.ca website | View Concentré de recherche: Où l'on optimise un test de laboratoire pour déterminer la compatibilité entre donneurs et receveurs | Other | Other |
Anti-M | Clarke G, Cote J, Lane D | 2018 | Blood.ca website | View Anti-M | Researchers | Basic research |
ResearchUnit: Modeling risk to ensure safety when considering changes to blood testing | O'Brien S | 2019 | Blood.ca website | View ResearchUnit: Modeling risk to ensure safety when considering changes to blood testing | Researchers | Basic research |
Diego System: Anti-Dia | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Diego System: Anti-Dia | Health care providers | Benchmarking and standard setting |
ResearchUnit: Perioperative treatment for patients with immune thrombocytopenia: Eltrombopag vs IVIG | Arnold DM | 2021 | Blood.ca website | View ResearchUnit: Perioperative treatment for patients with immune thrombocytopenia: Eltrombopag vs IVIG | Health care providers | Clinical research |
Circular of information for the use of human blood components: Platelets | Stewart T | 2022 | Blood.ca website | View Circular of information for the use of human blood components: Platelets | Health care providers | Benchmarking and standard setting |
ResearchUnit: Dodging disinfection: biofilm-forming skin bacteria can resist disinfectants | Ramirez-Arcos S | 2014 | Blood.ca website | View ResearchUnit: Dodging disinfection: biofilm-forming skin bacteria can resist disinfectants | Other | Other |
Circular of information for the use of human blood components: Red blood cells, Leukocytes Reduced (LR) | Jenkins C | 2018 | Blood.ca website | View Circular of information for the use of human blood components: Red blood cells, Leukocytes Reduced (LR) | Health care providers | Benchmarking and standard setting |
Circular of information for the use of human blood components: Hematopoietic progenitor cells (HPC), cord blood | Jenkins C | 2020 | Blood.ca website | View Circular of information for the use of human blood components: Hematopoietic progenitor cells (HPC), cord blood | Health care providers | Benchmarking and standard setting |
Système Lewis : les anticorps anti-Lewis | Peng S, Meunier D | 2019 | Blood.ca website | View Système Lewis : les anticorps anti-Lewis | Health care providers | Benchmarking and standard setting |
Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC), Cord Blood | Jenkins C | 2021 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
FAQ: Canadian Blood Services Platelet Bacterial Testing | Khandelwal A, Ramirez-Arcos S, Bigham M | 2021 | Blood.ca website | View FAQ: Canadian Blood Services Platelet Bacterial Testing | Health care providers | Other |
ResearchUnit: Novel discovery reveals new diagnostic markers and treatment targets for bleeding disorder | Ni H | 2015 | Blood.ca website | View ResearchUnit: Novel discovery reveals new diagnostic markers and treatment targets for bleeding disorder | Other | Other |
Transfusion-related acute lung injury (TRALI) | Petraszko T | 2019 | Blood.ca website | View Transfusion-related acute lung injury (TRALI) | Researchers | Clinical research |
Concentré de recherche: Transfusion de culots globulaires?: lien entre la non-concordance des sexes et la mortalité | Zeller M | 2019 | Blood.ca website | View Concentré de recherche: Transfusion de culots globulaires?: lien entre la non-concordance des sexes et la mortalité | Health care providers | Clinical research |
ResearchUnit: Improving quality testing of stem cells for patients | Pineault N | 2020 | Blood.ca website | View ResearchUnit: Improving quality testing of stem cells for patients | Researchers | New or improved product or process |
Testing and management of fetal and neonatal alloimmune thrombocytopenia | Meunier D, Clarke G | 2020 | Blood.ca website | View Testing and management of fetal and neonatal alloimmune thrombocytopenia | Health care providers | Benchmarking and standard setting |
Déclaration des réactions transfusionnelles indésirables | Yan M | 2021 | Blood.ca website | View Déclaration des réactions transfusionnelles indésirables | Health care providers | Benchmarking and standard setting |
Concentré de recherche: Suggestion concernant le mécanisme en jeu dans la thrombocytopénie thrombotique induite par le vaccin | Batarfi K | 2021 | Blood.ca website | View Concentré de recherche: Suggestion concernant le mécanisme en jeu dans la thrombocytopénie thrombotique induite par le vaccin | Researchers | Clinical research |
FAQ: Canadian Blood Services platelet bacterial screening | Khandelwal A, Ramirez-Arcos S, Bigham M | 2022 | Blood.ca website | View FAQ: Canadian Blood Services platelet bacterial screening | Health care providers | Benchmarking and standard setting |
FAQ : Le sang total déleucocyté à la Société canadienne du sang | Mack J | 2022 | Blood.ca website | View FAQ : Le sang total déleucocyté à la Société canadienne du sang | Health care providers | New or improved product or process |
Circulaire d'information utilisation de composants sanguins humains: Sang total | Stewart T | 2022 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Sang total | Health care providers | Benchmarking and standard setting |
Concentré de recherche: Comment se comportent les bactéries lors de la fabrication des plaquettes? | Ramirez-Arcos S | 2017 | Blood.ca website | View Concentré de recherche: Comment se comportent les bactéries lors de la fabrication des plaquettes? | Researchers | Basic research |
Platelet product quality remains high after seven days of storage | Serrano K, Schubert P, Devine D | 2017 | Blood.ca website | View Platelet product quality remains high after seven days of storage | Health care providers | New or improved product or process |
ResearchUnit: A model for change: predicting the impact of system-wide improvements | Blake J | 2018 | Blood.ca website | View ResearchUnit: A model for change: predicting the impact of system-wide improvements | Other | New or improved product or process |